more information

Category:

Biologically Active Peptides

reference

1. A. Krause, S. Neitz, H.-J. Mägert, A. Schulz, W.-G. Forssmann, P. Schulz-Knappe, and K. Adermann, FEBS Lett., 480, 147 (2000). (Original; LEAP-1)
2. C.H. Park, E.V. Valore, A.J. Waring, and T. Ganz, J. Biol. Chem., 276, 7806 (2001). (Original; Hepcidin)
3. C. Pigeon, G. Ilyin, B. Courselaud, P. Leroyer, B. Turlin, P. Brissot, and O. Loréal, J. Biol. Chem., 276, 7811 (2001). (Primary Structure: GenBank Accession No. AF344185)
4. G. Ilyin, B. Courselaud, M.-B. Troadec, C. Pigeon, M. Alizadeh, P. Leroyer, P. Brissot, and O. Loréal, FEBS Lett., 542, 22 (2003). (Original; Mouse Hepcidin 1 & 2)
5. A. Krause, R. Sillard, B. Kleemeier, E. Klüver, E. Maronde, J.R. Conejo-García, W.G. Forssmann, P. Schulz-Knappe, M.C. Nehls, F. Wattler, S. Wattler, and K. Adermann, Protein Sci., 12, 143 (2003). (Original)
6. E. Nemeth, M.S. Tuttle, J. Powelson, M.B. Vaughn, A. Donovan, D. McVey Ward, T. Ganz, and J. Kaplan, Science, 306, 2090 (2004). (Ferroportin; Hepcidin Receptor)
7. T. Ganz and E. Nemeth, Am. J. Physiol. Gastrointest. Liver Physiol., 290, G199 (2006). (Review)
8. G. Nicolas, C. Chauvet, L. Viatte, J.L. Danan, X. Bigard, I. Devaux, C. Beaumont, A. Kahn, and S. Vaulont, J. Clin. Invest., 110, 1037 (2002). (Pharmacol.; Regulation of Hepcidin mRNA)